Strafford will be offering a webcast entitled "Overcoming §103 Rejections for Biotech and Chemical Patents: Recent Decisions and USPTO Guidance" on November 16, 2017 from 1:00 to 2:30 pm (EST).  Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner, Amelia Feulner Baur of McNeill Baur, and Amanda K. Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel for overcoming §103 rejections for biotech and chemical patents, and review recent judicial and PTAB case law and offer insights to address §103 rejections.  The webinar will review the following issues:

• What evidentiary support should counsel provide to bolster its assertion of validity/patentability?
• What tactics should patent counsel implement to overcome §103 rejections for biotech and chemical patents?
• How can patent counsel guide applicants during patent application drafting to reduce the likelihood of rejection?

The registration fee for the webcast is $297.  Those interested in registering for the webinar, can do so here.